TrovaGene (TROV) stock price, revenue, and financials

TrovaGene market cap is $10.9 m, and annual revenue was $244.63 k in FY 2019

$10.9 M

TROV Mkt cap, 27-Mar-2020

$244.6 K

TrovaGene Revenue FY, 2019
TrovaGene Gross profit (FY, 2019)244.6 K
TrovaGene Gross profit margin (FY, 2019), %100%
TrovaGene Net income (FY, 2019)-16.4 M
TrovaGene EBIT (FY, 2019)-16.7 M
TrovaGene Cash, 31-Dec-201910.2 M
TrovaGene EV1.6 M

TrovaGene Income Statement

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

450.4k259.2k280.2k312.8k381.1k505.4k378.3k244.6k

Revenue growth, %

(90%)12%22%

Cost of goods sold

15.4k629.2k1.7m1.8m597.5k

Gross profit

264.7k(316.4k)(1.3m)(1.3m)(219.1k)244.6k

Gross profit Margin, %

94%(101%)(354%)(258%)(58%)100%

Sales and marketing expense

2.7m6.4m11.5m2.7m

R&D expense

1.9m3.9m6.7m10.6m15.0m7.9m8.2m11.2m

General and administrative expense

3.4m7.0m5.8m7.9m11.5m11.5m8.0m5.8m

Operating expense total

5.3m10.9m15.2m25.0m38.8m24.3m16.8m16.9m

EBIT

(4.8m)(10.7m)(14.9m)(25.3m)(40.1m)(25.6m)(17.1m)(16.7m)

EBIT margin, %

(1077%)(4124%)(5334%)(8080%)(10535%)(5064%)(4508%)(6818%)

Interest expense

1.4m

Interest income

147.9k219.4k234.2k

Investment income

3.7k12.2k57.3k

Income tax expense

Net Income

(11.6m)(11.8m)(14.3m)(27.5m)(39.2m)(24.9m)(16.5m)(16.4m)

Quarterly

USDQ1, 2012Q2, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

34.2k41.5k119.1k49.0k43.8k111.0k55.6k57.2k127.0k49.3k57.3k120.5k103.4k89.1k95.0k102.0k123.3k100.1k111.8k88.4k162.0k138.3k51.7k

Cost of goods sold

176.4k80.0k173.5k309.3k409.5k424.6k616.4k338.2k473.2k366.3k204.4k26.7k

Gross profit

(49.5k)(30.7k)(116.2k)(188.8k)(306.1k)(335.4k)(521.4k)(236.2k)(349.9k)(266.2k)(92.6k)61.7k162.0k138.3k51.7k

Gross profit Margin, %

(39%)(62%)(203%)(157%)(296%)(376%)(549%)(232%)(284%)(266%)(83%)70%100%100%100%

Sales and marketing expense

569.6k589.8k540.6k794.7k1.9m1.8m3.1m3.1m2.9m1.4m615.0k419.9k

R&D expense

337.4k477.2k802.2k943.8k915.5k1.4m1.4m2.0m2.2m2.7m2.5m3.2m4.1m3.9m4.3m981.7k1.4m1.9m2.0m1.8m2.6m2.8m2.8m

General and administrative expense

827.0k809.9k1.7m1.5m2.2m1.4m1.3m1.5m1.8m2.0m1.9m4.0m2.5m2.7m2.2m4.1m3.7m2.5m2.2m1.7m1.5m1.5m1.4m

Operating expense total

1.2m1.3m2.5m2.4m3.1m3.4m3.3m4.0m4.8m6.6m6.3m10.3m9.7m9.6m9.6m5.7m5.4m4.4m4.3m3.9m4.1m4.4m4.3m

EBIT

(1.1m)(1.2m)(2.4m)(2.4m)(3.1m)(3.3m)(3.2m)(3.9m)(4.8m)(6.6m)(6.4m)(10.5m)(10.0m)(9.9m)(10.1m)(5.9m)(5.8m)(4.7m)(4.4m)(3.9m)(4.0m)(4.2m)(4.2m)

EBIT margin, %

(3309%)(3001%)(2006%)(4845%)(7034%)(2938%)(5827%)(6889%)(3818%)(13440%)(11181%)(8680%)(9652%)(11137%)(10654%)(5772%)(4701%)(4649%)(3971%)(4363%)(2446%)(3052%)(8140%)

Interest expense

668.0355.0k429.4k431.9k16.5k2.5k35.3k

Interest income

85.9k64.7k69.8k53.7k

Investment income

44.02.4k2.1k3.5k6.4k9.3k17.4k

Net Income

(1.2m)(3.4m)(1.1m)(5.3m)(4.4m)(3.2m)(1.1m)(5.4m)(7.2m)(10.2m)(2.7m)(10.3m)(10.2m)(10.2m)(10.0m)(8.0m)(4.3m)(4.8m)(3.7m)(3.8m)(3.9m)(4.1m)(4.1m)

TrovaGene Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

10.8m25.8m27.3m67.5m13.9m8.2m11.5m10.2m

Accounts Receivable

168.4k79.0k56.7k98.7k100.5k77.1k167.8k203.5k

Prepaid Expenses

60.0k152.8k369.3k789.3k1.2m1.1m955.0k

Inventories

Current Assets

11.0m26.1m27.7m68.4m39.0m9.5m12.8m11.4m

PP&E

254.7k750.6k840.4k2.7m3.8m2.4m1.3m877.8k

Total Assets

11.7m27.2m28.9m71.4m44.0m12.3m14.2m13.1m

Accounts Payable

175.7k286.6k747.8k1.0m1.1m825.2k664.8k656.3k

Short-term debt

198.2k1.9m5.2m2.4m1.3m

Current Liabilities

730.4k2.0m4.5m8.2m7.8m3.9m3.0m4.8m

Long-term debt

323.0k13.1m11.2m861.0k

Total Debt

198.2k15.0m5.2m2.4m1.3m861.0k

Total Liabilities

9.5m6.8m20.5m22.7m24.2m5.8m4.1m5.8m

Common Stock

1.5k1.9k1.9k3.0k5.3k7.7k8.3k

Preferred Stock

96.060.060.060.060.060.060.0

Additional Paid-in Capital

57.4m87.4m89.7m157.6m167.9m179.5m202.3m217.2m

Retained Earnings

(55.2m)(67.0m)(81.4m)(108.9m)(148.1m)(173.0m)(192.2m)(208.9m)

Total Equity

2.2m20.4m8.3m48.7m19.8m6.5m10.1m7.3m

Debt to Equity Ratio

0 x0.1 x0.1 x0.2 x

Debt to Assets Ratio

0 x0.1 x0.1 x0.1 x

Financial Leverage

5.4 x1.3 x3.5 x1.5 x2.2 x1.9 x1.4 x1.8 x

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

586.8k9.3m7.8m9.2m8.3m27.8m22.9m34.7m31.2m44.0m41.3m74.1m60.0m22.6m22.6m10.2m7.8m7.4m6.7m18.5m15.1m11.3m10.8m9.0m

Accounts Receivable

76.5k106.0k128.2k58.1k56.5k69.6k129.3k59.9k62.4k59.4k99.7k67.0k61.9k158.5k85.2k80.3k157.4k178.1k114.3k124.1k128.6k115.7k122.3k152.0k

Prepaid Expenses

42.4k29.7k57.3k127.1k164.7k129.4k262.2k295.8k348.0k418.0k508.4k600.9k840.7k877.9k946.4k845.8k713.9k939.2k1.1m1.0m849.1k890.7k906.5k792.5k

Current Assets

705.8k9.4m8.0m9.3m8.5m28.0m23.3m35.0m31.6m44.5m41.9m74.8m60.9m51.6m48.0m29.7m8.7m8.6m7.8m19.6m16.0m12.3m11.8m10.0m

PP&E

114.3k149.5k208.4k330.3k570.9k740.3k859.6k817.0k841.4k1.0m1.4m1.8m4.7m4.7m4.7m3.6m3.3m3.1m2.2m1.8m1.6m293.4k252.1k271.4k

Total Assets

1.2m10.0m8.6m10.2m9.6m29.2m24.5m36.2m32.8m45.8m43.6m77.0m66.0m56.7m53.0m33.9m12.6m12.2m10.4m21.8m17.9m14.5m13.9m11.9m

Accounts Payable

947.0k530.8k140.0k323.4k297.8k159.0k427.4k379.7k461.8k484.7k1.1m1.1m1.3m1.1m925.2k968.4k602.7k675.5k651.7k565.4k476.3k466.7k525.7k492.4k

Short-term debt

63.0k147.6k200.8k752.7k3.1m2.3m3.7m5.9m6.1m801.0k3.9m1.6m1.5m1.2m

Current Liabilities

1.5m1.2m757.5k1.2m1.5m1.4m2.0m2.0m3.1m5.3m5.0m7.0m10.1m10.9m6.6m9.0m7.5m5.1m3.9m3.2m2.7m3.3m3.7m4.2m

Long-term debt

252.2k370.4k274.9k14.7m14.0m12.0m12.9m11.5m10.4m9.0m15.6m12.7m1.5m1.3m1.1m

Total Debt

315.2k147.6k200.8k14.7m752.7k3.1m2.3m3.7m5.9m6.1m801.0k3.9m1.6m1.5m1.2m1.5m1.3m1.1m

Total Liabilities

5.5m4.5m3.6m8.7m12.1m8.0m6.7m18.9m20.4m22.3m25.5m22.2m24.8m24.2m26.2m23.2m9.0m8.3m5.7m4.3m3.9m4.8m5.0m5.3m

Common Stock

6.7k1.4k1.4k1.6k1.6k1.9k1.9k1.9k1.9k2.4k2.5k3.0k3.0k3.0k3.1k3.1k3.1k3.8k5.9k7.2k7.7k7.9k8.0k8.1k

Preferred Stock

96.096.096.078.078.060.060.060.060.060.060.060.060.060.060.060.060.060.060.066.060.0260.060.060.0

Additional Paid-in Capital

40.4m53.7m53.8m57.9m59.1m87.1m88.0m88.6m89.1m112.1m116.9m156.4m160.3m161.9m166.3m168.8m169.7m174.4m182.4m201.7m202.0m207.7m210.7m212.5m

Retained Earnings

(44.8m)(48.2m)(48.9m)(56.3m)(61.6m)(66.0m)(70.2m)(71.3m)(76.7m)(88.6m)(98.8m)(101.5m)(119.2m)(129.4m)(139.6m)(158.1m)(166.2m)(170.5m)(177.7m)(184.3m)(188.0m)(196.4m)(200.5m)(204.6m)

Total Equity

(4.3m)5.5m5.0m1.5m(2.5m)21.1m17.8m17.3m12.4m23.6m18.1m54.9m41.2m32.6m26.8m10.7m3.5m3.9m4.7m17.5m14.0m9.7m8.8m6.7m

Debt to Equity Ratio

0 x0 x0.1 x0.1 x0.1 x0.1 x0.1 x0.2 x0 x0.4 x0.5 x0.4 x0.3 x

Debt to Assets Ratio

0 x0 x0 x0.1 x0.1 x0 x0.1 x0.1 x0 x0.1 x0.1 x0.1 x0.1 x

Financial Leverage

-0.3 x1.8 x1.7 x6.6 x-3.9 x1.4 x1.4 x2.1 x2.7 x1.9 x2.4 x1.4 x1.6 x1.7 x2 x3.2 x3.6 x3.1 x2.2 x1.2 x1.3 x1.5 x1.6 x1.8 x

TrovaGene Cash Flow

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

(1.2m)(4.6m)(5.2m)(1.1m)(6.4m)(10.8m)(3.2m)(4.3m)(9.6m)(7.2m)(17.4m)(20.1m)(10.3m)(20.5m)(30.7m)(10.0m)(18.0m)(22.3m)(4.8m)(8.5m)(12.3m)(3.9m)(8.0m)(12.2m)

Depreciation and Amortization

6.2k14.0k26.3k17.8k43.9k85.5k53.5k111.3k169.6k68.5k153.0k250.6k156.8k489.7k693.5k331.0k646.0k957.0k252.5k483.5k701.8k45.9k87.2k130.2k

Accounts Receivable

22.6k(6.9k)(29.0k)110.3k111.9k98.8k(50.3k)19.1k16.6k(2.7k)(43.0k)(231.7k)36.8k(59.8k)13.6k20.1k(57.0k)(77.7k)72.7k62.9k58.4k52.1k45.5k15.7k

Accounts Payable

93.3k(213.4k)(701.0k)316.6k629.8k462.1k14.5k152.6k632.9k(383.6k)28.2k616.4k1.1m1.5m2.5m(360.6k)280.5k(1.9m)51.0k638.7k383.0k3.6k387.0k837.6k

Cash From Operating Activities

(905.1k)(2.2m)(3.6m)(1.6m)(3.4m)(5.5m)(2.8m)(5.5m)(8.9m)(4.7m)(10.2m)(15.3m)(6.9m)(15.0m)(22.0m)(8.8m)(13.4m)(19.9m)(2.9m)(6.1m)(9.6m)(3.4m)(6.8m)(10.0m)

Purchases of PP&E

(98.0k)(141.0k)(212.2k)(93.4k)(360.1k)(571.1k)(118.5k)(133.7k)(235.6k)(247.1k)(688.0k)(1.3m)(352.0k)(670.9k)(797.8k)(11.5k)(20.7k)(136.3k)(5.1k)(5.1k)(5.1k)(5.3k)(5.3k)(67.6k)

Cash From Investing Activities

(98.0k)(141.0k)(212.2k)(93.4k)(360.1k)(571.1k)(118.5k)(133.7k)(235.6k)(247.1k)(688.0k)(1.3m)(352.0k)(28.6m)(25.2m)5.2m24.0m23.9m(5.1k)(36.6k)22.8k(5.3k)(5.3k)(67.6k)

Long-term Borrowings

(919.9k)(2.3m)(8.9m)(156.5k)(15.3m)(15.5m)(156.5k)(1.2m)(1.2m)

Cash From Financing Activities

889.5k10.9m10.9m66.5k1.2m23.0m(48.6k)14.4m14.4m21.7m24.9m63.4m(236.0k)(1.3m)2.4m(156.5k)(16.8m)(10.4m)1.3m16.4m16.4m3.2m6.1m7.6m

Net Change in Cash

(113.6k)8.6m7.1m(1.7m)(2.5m)17.0m(3.0m)8.8m5.3m16.7m14.0m46.9m(7.5m)(44.9m)(44.9m)(3.7m)(6.1m)(6.5m)(1.6m)10.3m6.8m(123.1k)(661.9k)(2.4m)

Interest Paid

3.3k6.6k71.8k248.5k265.1k530.3k795.4k276.2k536.7k806.2k300.0k630.0k650.3k16.4k22.5k22.5k

Income Taxes Paid

7.7k7.7k7.7k2.4k2.4k2.4k800.0800.0800.04.6k4.6k800.0800.0800.0800.0800.0800.0800.0

TrovaGene Ratios

USDY, 2019

EV/EBIT

-0.1 x

EV/CFO

-0.1 x

Revenue/Employee

20.4k

Financial Leverage

1.8 x

TrovaGene Employee Rating

2.35 votes
Culture & Values
2.7
Work/Life Balance
2.4
Senior Management
2.8
Salary & Benefits
3.2
Career Opportunities
2.3
Source